$5.64 +0.02 (0.36%) Cyclacel Pharmaceuticals Inc - NASDAQ

Sep. 26, 2016 | 02:28 PM
Key Statistics
Last Trade: 5.64
Trade Time: Sep 26 02:28 PM Eastern Daylight Time
Change: +0.02 (0.36%)
Prev Close: 5.62
Open: 5.53
Bid: 5.60
Ask: 5.71

Competitors

Ticker Name Volume % Change
MSTX Mast Therapeutics Inc. 23.15M -4.28%
MDVN Medivation Inc. 16.11M +0.42%
BLRX BioLineRx Ltd 9.19M +26.73%
GILD Gilead Sciences Inc. 7.53M -0.18%
MNKD MannKind Corporation 7.51M -9.75%

CYCC Stock Analysis

  1. No results found.

Partner Headlines

  1. Benzinga's Weekend M&A Chatter

    Benzinga | Nov. 29, 2015 | 19:44PM EST
  2. Benzinga's Top Initiations

    Benzinga | Oct. 16, 2015 | 09:27AM EST
  3. Cyclacel Announces Presentation of Molecular Rationale for Clinical Development of ...

    Benzinga | Sep. 17, 2015 | 07:04AM EST
  4. Cyclacel Announces First Patient Dosed in IST of CDK Inhibitor Seliciclib in Cushing's ...

    Benzinga | Jul. 2, 2015 | 07:04AM EST
  5. Wilbur Ross Buys Two New Stakes in First Quarter

    GuruFocus | Jun. 15, 2015 | 16:59PM EST
  6. Morning Market Losers

    Benzinga | Dec. 16, 2014 | 09:57AM EST